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Abstract
Background: Cardiovascular disorders (CVD) are the single greatest cause of mortality worldwide. In the UK, the
National Health Service (NHS) has launched an initiative of health checks over and above current care to tackle
CVD. However, the uptake of Health Checks is poor in disadvantaged communities. This protocol paper sets out a
UK-based study (Sussex and Nottingham) aiming to co-produce a community delivered CVD risk assessment and
coaching intervention to support community members to reduce their risk of CVD.
The overall aim of the project is to implement a tailored-to-context community engagement (CE) intervention on
awareness of CVD risks in vulnerable populations in high, middle and low-income countries. The specific objectives
of the study are to enhance stakeholder’ engagement; to implement lifestyle interventions for cardiovascular
primary prevention, in disadvantaged populations and motivate uptake of NHS health checks.
Methods: This study uses both qualitative and quantitative methods in three phases of evaluation, including pre-,
per- and post-implementation. To ensure contextual appropriateness the ‘Scaling-up Packages of Interventions for
Cardiovascular disease prevention in selected sites in Europe and Sub-Saharan Africa: An implementation research’
(SPICES) project will organize a multi-component community-engagement intervention. For the qualitative component,
the pre-implementation phase will involve a contextual assessment and stakeholder mapping, exploring potentials for CVD
risk profiling strategies and led by trained Community Health Volunteers (CHV) to identify accessibility and acceptability.
The per-implementation phase will involve healthy lifestyle counselling provided by CHVs and evaluation of the outcome
to identify fidelity and scalability. The post-implementation phase will involve developing sustainable community-based
strategies for CVD risk reduction. All three components will include a process evaluation. A stepped wedge cluster
randomised trial of the roll out will focus on implementation outcomes including uptake and engagement and changes in
risk profiles. The quantitative component includes pre and post-intervention surveys. The theory of the socio-ecological
framework will be applied to analyse the community engagement approach.
Discussion: Based on the results ultimately a sustainable community engagement-based strategy for the primary
prevention of CVD risk will be developed to enhance the performance of NHS health care in the UK. The Trial Registration
number is ISRCTN68334579.
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Introduction
Cardiovascular disorders (CVD) are the single greatest
cause of mortality worldwide each year, estimated to con-
tribute to 31% of all deaths globally [1]. Tackling CVD is
an international priority and there have been many global
initiatives such as the “Global Hearts” programme, a pack-
age launched by the World Health Organisation (WHO)
and partners, to enhance the prevention and control of
CVD. Some risk factors for CVD are non-modifiable, such
as age, ethnicity and family history [2]. Some other risk
factors for CVD are modifiable, such as smoking, a lack of
physical activity, being overweight, lower consumption of
fruit and vegetables, high blood pressure, diabetes and
high cholesterol [2]. These risk factors can be changed
through lifestyle or behavioural modifications. There is
evidence of a social gradient in the prevalence of CVD,
which points to associations between social and financial
deprivation, vulnerability and risk factors for CVD [3]. In
2015, CVD was the leading cause of mortality in the con-
text of all chronic diseases, accounting for 27 and 25% of
deaths in men and women respectively, in the UK [2].
Coronary heart disease (CHD) and stroke were the main
CVDs responsible for this mortality of men and women
across all ages. As per British Heart Foundation report in
2017 CVD has a huge financial burden with annual associ-
ated healthcare costs estimated to be £9 billion annually
in the UK [2]. The UK has a standardised CVD death rate
of 265.1 per 100,000 [2].
In the UK, the National Health Service (NHS) has
launched the Health Check initiative aimed to reduce
CVD. It is a national risk assessment and management
programme, free to adults aged 40 to 74 living in
England, who do not currently have any vascular dis-
orders and are not being treated for certain risk factors
such as diabetes [4]. It aims to assess the 10-year risk of
CV events and disorders. Risk is assessed using QRISK2
[5], a tool which involves collection of the following in-
formation: age, gender, ethnicity, smoking status, family
history of CHD, body mass index (BMI), cholesterol test,
systolic and diastolic blood pressure, levels of physical
activity, and alcohol consumption. Attendees receive a
low (< 10% chance of event in 10 years), medium (> 10%
but < 20%), or high (> 20%) 10-year cardiovascular
(QRISK2) score. Above the 10% cut-off, attendees are
offered a discussion with a qualified person, such as a
nurse, about lifestyle and motivation to change, which
may include goal setting and plans for follow up.
Patients may also be offered medication for cholesterol
and blood pressure. The NHS Health Check is
recommended to be undertaken every 5 years.
Modelling predicted that the NHS Health Check could
prevent 1600 heart attacks and strokes each year if imple-
mented as intended [6]. Whilst evidence suggests that the
Health Check programme has the potential to reduce CVD
events and has therefore been rolled out nationally across
the UK, its implementation has been poor, especially in
some of the most disadvantaged groups at highest risk
of developing CVD. In 2014, Public Health England
(PHE) issued a call for action to increase the uptake
rate of NHS Health Checks to 75% [7] and to increase
awareness of risk and engagement with existing
resources. Yet, as of 2017, current uptake remains far
from this target with current predictions suggesting
only 40% of the eligible population will receive one [8],
due to the fact that uptake is low (48%) even when
Health Checks are offered [8, 9].
Data from some regions with very large ethnic minority
communities and socio-economically challenged popula-
tions showed that only 45% of patients who were invited
for the check attended and subsequently received some
form of counselling when they needed it. The current
study uses the term socio economically challenged (SEC)
or disadvantaged population based on a study where SEC
was assessed using the Townsend score using 2001
census-derived measures of overcrowding, car ownership
and education available at lower super output area. This
has been found by linking the individuals’ postcode to
lower super output area, approximately 150 households
[10]. Authors have also suggested that higher uptake in
SEC communities would reduce the possibility of exacer-
bation of inequalities [10]. Difficulty with accessing gen-
eral practices, especially among socially vulnerable groups,
has been highlighted as a common barrier to attendance
at Health Checks [11]. A community-based engagement
approach, which takes the CVD risking profiling and affili-
ated advice processes outside of the formal healthcare fa-
cility setting, has the potential to improve access to Health
Checks and could be an effective and scalable way for im-
proving the implementation and uptake of Health Checks.
Community engagement (CE) has been conceptualised as
“the process of working collaboratively with and through
groups of people affiliated by geographic proximity, special
interest, or similar situations, to address issues affecting
the well-being of those people” [12]. A review of commu-
nity engagement interventions found them to be effective
in improving health behaviours (such as physical activity),
health consequences and psychological outcomes (i.e. self-
efficacy and perceived social support) [13]. Community-
based intervention programmes have been implemented
to increase the uptake of cancer screening programmes.
The programmes have been found to be effective in
increasing outcomes such as recognition, receipt and
maintenance of screening behaviours [14]. The CE
approach offers the opportunity for task-shifting and own-
ing the programme, whereby trained non-healthcare-
professionals can perform CVD risk profiling assessments
to individuals who might not otherwise be captured
by the formal care pathway.
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There is evidence that CVD risk assessments can be
successfully delivered by Community Health Workers
(CHWs), outside or inside the healthcare system. An
observational study conducted in Bangladesh,
Guatemala, Mexico and South Africa has demon-
strated that CHWs who are inhabitants of their local
communities and were fluent in the community’s pre-
dominant language, can perform community-based
screenings to predict CVD risk as effectively as physi-
cians and nurses when using the non-laboratory-based
Gaziano CVD risk scoring tool [15]. CHWs were
trained for 1–2 weeks, and results showed a 96.8%
agreement between risk scores assigned by CHWs
and healthcare professionals. However, a question re-
mains whether the model taken in the global South
could be transferrable to the global North, but it is at
least plausible that a community-based engagement
approach will be effective for increasing the uptake of
CVD risk assessment, particularly in disadvantaged
communities of the global North. There are examples
in the global North on community engagement in
health [16], and indeed the voluntary or ‘third sector’
have been considered key partners in the delivery of
health promotion initiatives in the community [17].
Authors have argued that because of the current eco-
nomic constraints with the formal healthcare system in
the UK, the focus should be upon supplementing a service
delivery model with an alternative community develop-
ment model [18]. The key aspect is supplementing formal
service delivery by utilizing communities’ ‘social capital’.
The term ‘social capital’ describes the various resources
that people may have through their relationships in
families, communities and other social networks. Social
capital bonds people together and helps them make links
beyond their immediate friends and neighbours [19].
For this compassionate community approach to
work, contextual appropriateness and cultural sensitiv-
ity of an intervention is crucial [20]. Following this
argument, the SPICES project (Scaling-up Packages of
Interventions for Cardiovascular disease prevention in
selected sites in Europe and Sub-Saharan Africa) in
two areas of England, East Sussex and Nottingham,
will co-produce a multi-component community-
engagement intervention focussed on delivering a
Health Check-style CVD risk screening intervention.
The UK SPICES project will use appropriate health
coaching and follow-up, in a community setting [21]
delivered by community volunteers. The specific objectives
of the project are:
1. To explore with stakeholders the potential for a
community engagement-based CVD primary
prevention programme to support or enhance the
NHS Health Check Programme.
2. To co-produce with the communities an evidence-
informed community-engagement intervention on
CVD risk, based on the NHS Health Check model,
tailored to the context in disadvantaged communities
in East Sussex and Nottingham.
3. To implement the intervention in the local
communities where it was co-produced, and:
– assess its effectiveness versus routine care.
– assess the fidelity, feasibility, acceptability, uptake
and scalability of the implementation.
– carry out a process evaluation of the intervention
and its implementation.
Para ID="Par17">The SPICES Project is a Horizon 2020
project financed by the European Commission that aims
to address the CVD burden [22]. The overall objective is
to implement and evaluate a comprehensive cardiovascu-
lar disease (CVD) prevention and care program at the
community level in five countries (Belgium, France, South
Africa, Uganda, and UK), to identify and compare barriers
and facilitators for implementation across study contexts
and to develop a learning community. The intervention
will be trialled and evaluated using a mixed methods ap-
proach using both qualitative and quantitative methods.
Methods
Theoretical model
SPICES is underpinned by the Consolidated Framework
for Advancing Implementation Research (CFAIR; 23),
and Reach, Effectiveness, Adoption, Implementation,
and Maintenance (sustainability) framework /RE-AIM
models [23]. It is a global health project, and thus needs
a socio-ecological framework for consistency between
teams [24]. This framework allows an understanding of
the multifaceted and interactive effects of personal, so-
cial and environmental factors that determine behaviour;
and for identifying behavioural and organisational
leverage points and intermediaries for health promotion
within organisations and communities.
Study design
A mixed-methods research methodology will be applied,
strategically combining qualitative and quantitative
methods at both sites. This approach will allow us to
model the iterative nature of coproduction and imple-
mentation research without compromising the rigour of
the study [25, 26]. The study will take place in three
phases:
– Pre-intervention; when stakeholder mapping and
local adaptation will be carried out.
– Per-Intervention roll out, recruitment and
evaluation.
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– Post-intervention evaluations and feedback [27]
Process evaluation will be conducted in all three
phases.
Processes
Stage 1: to explore the implementation context and co-
produce the intervention
To explore the context where the implementation will
take place we will carry out several mappings. These will
give us the context for recruitment and implementation
co-design.
They are as follows:
(a) Mapping the potential stakeholders: Mapping of the
stakeholders will be done to find out who are the
key stakeholders, where they come from, and what
they are looking for in relationship to the study
objectives [28]. To engage the community, it is
essential to map the community stakeholders (civil
society organisations) as they are the gatekeepers of
the community. Three levels of stakeholder
mapping will be carried out, namely at macro, meso
and micro levels.
Macro-level: Stakeholders will be identified via the
existing link of PI of the project in the
community through meetings with local public
health or other relevant departments and CSOs
and using online information. Interviews with this
category of stakeholders will provide insights into
implementation sustainability.
Meso-level: A strategic community volunteer
organisation mapping will be carried out to find
out the relevant organisations, through which
individual volunteers will be selected. This will
be done in three ways; using online searches,
personal contacts and snowballing. In-depth
interviews will be conducted to co-design a
sustainable intervention implementation.
Micro-level: An exploration will be undertaken
with volunteers and end-user groups to co-design
an acceptable and feasible intervention
implementation.
(b) Mapping the context: social mapping will be carried
out to explore the lifestyle context of the
community via observations.
(c) Training of volunteers by professional health
trainers and researchers following the current NICE
Public health guideline [PH6] ‘Behaviour change:
general approaches’ [29].
(d) CVD risk profiling by trained community health
volunteers (CHV) during the pre-implementation stage.
CHVs will be the persons who have been involved in
health-related volunteering for example volunteers who
worked in cancer prevention, health check, healthy lifestyle
etc. programme. They will be involved in the screening of
the CVD risk population and implement the designed
intervention.
Expected intervention
The final elements of the intervention will be co-
produced within each community setting, following the
mapping exercises outlined above on the contextual bar-
riers and enablers of intervention implementation. Data
from each site will contribute to a holistic intervention.
These four sites are geographically close to each other
and have similarities in socio-economic status so it is
likely that the interventions will be similar. However,
although the core components are similar, implemen-
tation within a setting/organization could be different.
As outlined in the CFAIR [30], interventions are usually
composed of a core component which is essential and
indispensable, and an adaptable periphery, which can
and should be tailored to the specific setting and users.
Core components Following identification of moderate
to high risk for CVD, the intervention will consist of
non-clinical (non-NHS) individual or group support
sessions within the community, focus on motivating
behaviour change. Each participant will be supported by
trained SPICES researchers or community health
workers to identify behaviour change goals, produce
action plans to achieve them, and problem solve in cases
of unexpected outcomes. All SPICES Interventions are
theoretically grounded in the theory of behaviour change
and deploy the strongest evidenced Behaviour Change
Techniques (BCTs) from the literature: Goal Setting,
Action Planning, Problem Solving, Motivational Interview-
ing, Feedback on progress towards goals, Feedback on the
health impact. The use of these six BCTs are focussed in
SPICES on five Target Behaviours: Reduce/cease smoking,
Increase moderate physical activity, Reduce the fat, salt,
and sugar content of the diet, Increase fibre, oily fish, fruit
and vegetable content of the diet, Reduce sedentary hours.
Community adaptation The exact elements of the sup-
port sessions will be tailored to individuals and their
community context, will be determined during iterative
co-design with community representatives, and will be
drawn from the following [31, 32]:
Step-I - Goal setting
Every participant should receive specific healthy lifestyle
counselling/feedback based on their individual item Inter-
HEART assessment scores (the moderate group). The feed-
back will be based on a review of international guidelines
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conducted as formative work for the SPICES project inter-
vention [33]. SPICES behaviour change support sessions will
be based on the best-evidenced approaches to healthy life-
style modification and community context and preferences.
The following screening self-report questionnaires
assess the benefit of possible behaviour changes in
relation to physical activities and dietary practices.
Selected questionnaires will be used for measuring the
impact of implementations;
1) International Physical Activity Questionnaire
(IPAQ, see Additional file 1) is an internationally
validated instrument to capture information about
weekly physical activity habits, behaviours and
routines.
2) The Dietary Approaches to Stop Hypertension
Questionnaire DASH-Q is a self-reporting lifestyle
questionnaire (see Additional file 2) to capture in-
formation about weekly dietary habits, routines and
behaviours, based around ‘Dietary Approach to
Stopping Hypertension’ [34].
3) Current behaviours audit: Using food and physical
activity diaries prepared by and provided to
participants by the SPICES research team,
participants will be encouraged to complete an audit
of 1 week of current dietary and physical activity
behaviours, habits and routines to establish a baseline
from which goals for change and improvement can
be set in negotiation with SPICES CHVs.
4) The Attitudes and Beliefs about Cardiovascular Disease
(ABCD) Risk Questionnaire, licenced under Creative
Commons Attribution 4.0 International Licence,
developed by Maria Woringer et al. [35]. to assess
participant perception of personal heart health risk.
5) The EQ-5D-5 L internationally validated Quality of
Life self-reporting questionnaire.
Step-II - Action planning by the participants
Participants will be asked to create an action plan with
appropriate goal setting for two behaviours (diet and ex-
ercise habits) in relation to when, where and how they
will undertake, for example, physical activity (based on
the item stems used by Luszczynska & Schwarzer [36];
when the physical activity will be performed, where it
will be performed, how often it will be performed.
The way goals are reached and plans recorded will be
co-designed with key stakeholders.
Step III - Problem-solving
CHVs will help participants to analyse any factors
which may influence their ability to achieve the goals
and to generate strategies which could help them over-
come these barriers.
CHVs will use Motivational Interviewing techniques
about health, social and environmental, and emotional
barriers and consequences. Culturally and context-
sensitive information will be provided (both verbally and
in the form of leaflets) about the importance of eating
healthily, being physically active, and not smoking for
positive outcomes on physical and mental health.
Stage 2: intervention roll out, recruitment and evaluation
This will be an open-label, stepped wedge cluster rando-
mised controlled trial, examining fidelity, feasibility,
acceptability, uptake and scalability of the intervention.
Eligible population and setting
Economically disadvantaged, lower socio-economic status
(SES) postcodes, will be identified using the overall Index of
Multiple Deprivation [37]; Participants’ SES will be deter-
mined by their postcode of residence. Any resident aged 18
or above living in the study postcode areas will be eligible
to take part in the baseline assessment for the study.
(a) Study sample size and power calculation
The sample size calculation for the quantitative study
used statistical modelling for a stepped wedge design, ran-
domising community centres over time with the Inter-
HEART score as the outcome (90% power for 5%
significance, small effect size (Cohen’s D) = 0.25, intraclus-
ter correlation coefficient of 0.05, control clusters crossing
to intervention in 4 steps, participant autocorrelation = 0.7
and cluster autocorrelation = 0.9), which requires a total of
at least 144 persons. This needs approximately 200–300
people across the two sites as we expect a high level of attri-
tion (as much as 50%). At least 1500 community members
will need to be screened to achieve this recruitment [38].
(b) Recruitment of community Health volunteers and
trial participants
Community Health Volunteers (CHVs) will be recruited
to perform CVD risk profiling assessments through a com-
bination of ‘doorstep outreach’ and ‘intermediary organisa-
tion recruitment’ approaches in East Sussex and through
existing community and neighbourhood groups with the
assistance of partners such as Self-Help UK, the Renewal
Trust, Nottingham CVS and others in Nottingham. For re-
cruitment of trial participants, we will use similar commu-
nity networks, and endeavour to use quota sampling, in
that we will seek to ensure the inclusion of high, low and
median income neighbourhood residents, citizens from the
South Asian and African diasporas; and will encourage
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participants to refer others to the researchers who may be
able to potentially contribute or participate in the study.
(c) Baseline screening of CVD risk
Participants will fill in the validated non-laboratory
based InterHEART score to determine suitability for the
trial. The InterHEART scoring tool requires minimal re-
sources which is practical for use within the community.
There is also evidence to suggest that the InterHEART
can reliably predict the incidence of CVD and death in
low, middle, and high-income countries for a mean
follow-up of 4.1 years [39]. Risk is expressed as a score
from the InterHEART: 0–9 (Low risk), 10–15 (moderate
risk), and 16–48 (high risk). The InterHEART scoring
tool will be inserted onto a mHealth platform so that the
trained CHVs can easily administer them during com-
munity engagement and contact, and online data will
directly reach the University repository in real time from
the respondents’ device. The moderate risk (amber)
score population will be selected for participation in the
intervention (= score of 10 or higher), and will fill out
the self-completion survey InterHEART scoring every
3 months [40].
(d) Clinical outcome and follow-up
The primary outcome will be the change in the CVD
risk score among people who complete the community
delivered CVD risk assessment and coaching (before/
after and between groups). In addition, a by-product
outcome will be gathered from participants identified as
‘high risk’ (who are not part of the sample) during the
screening process. This group of participants will be
signposted to their GP surgery requesting a) a formal
CVD risk check-up and b) completed NHS Health
Checks. The following secondary outcomes will be gath-
ered from such participants identified as ‘high risk’: 1)
Numbers of participants who a) self-referred (defined as
having contacted their GP surgery requesting for a for-
mal check-up) and b) completed the NHS Health Check,
2) Self-reported lifestyle risk factors gathered through
survey instruments and interviews. 3) Observed data on
all participants’ age, gender, ethnicity, postcode, hip to
waist ratio, gathered by trained volunteers. Quantitative
analysis of changes in behavioural intention, target
behaviours, and measurable CVD risk. The outcome
will be assessed at multiple time points after the
interventions, once every 3 months, to see whether
the behavioural change has been sustained. The
per-implementation phase data will provide an
insight of the challenges of implementation.
Amendment in the design of implementation may tailored
accordingly.
(e) Post-intervention qualitative evaluation and
feedback
In the post-intervention phase, a qualitative evaluation
will be carried out during which the following imple-
mentation parameters will be assessed:
1. The impact on awareness of CVD risks and
mitigating measures, amongst disadvantaged
populations of a community-based, non-clinical,
CVD risk scoring tool and education.
2. The impact of the community based non-clinical
CVD risk scoring tool and education on motiv-
ational healthy lifestyle among disadvantaged
populations.
3. The facilitators and barriers to the adoption of a
community-based CVD prevention implementation
programme, by target populations.
4. The perspectives of participants regarding their
experience and meaning of the intervention.
These will be explored with a subset of intervention
participants using focus groups or/and in-depth inter-
view and community mapping. Participants for the
qualitative component will include adult volunteers,
public health stakeholders and people within the com-
munity. The community volunteers will be selected via
community organisations and public health stakeholders
will be selected from the same area of the research site.
Community participants for the qualitative component
will be selected via the community volunteers. This
post-intervention qualitative study will include purpos-
ively selected trial participants.
The number of participants for the qualitative component
will be flexible. The number will be determined through the
principles of saturation and diversity. However, from
each site, we will aim to include at least 12 respondents
and a maximum of 30 respondents from different
categories [41, 42].
Stage 3: process evaluation of the intervention
To assess the fidelity of the conclusions concerning the
project’s effectiveness, ongoing assessment, monitoring,
and enhancement is important. If significant interven-
tion effects are observed, but fidelity was not assessed, it
cannot be determined if the effectiveness is attributable
to unintentionally added or omitted components. Bellg
and colleagues [43] propose that considerations of fidel-
ity should permeate all stages of the study: design of the
study, provision of training, delivery of the intervention,
receipt of the intervention, and re-enactment of skills.
As a result, we will carry out a process evaluation of the
project. This will be reached through Process Documen-
tation of all the stages of this project including
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community volunteers mapping, healthy lifestyle counsel-
ling, action planning and problem-solving.
Thirsk and Clark [44] argue how health-care interven-
tions need to be understood in ways that are responsive to
the complexities and intricacies of programs, people and
places. They emphasise the understanding of the compre-
hensive experience of the persons who are delivering and
receiving the intervention. Process Evaluation is a tool that
can capture the intervention experience. We will be
following the model designed by Moore et al. [45]; Fig. 1.
Data analysis
Flow of trial clusters and participants will be depicted in a
CONSORT 2010 Statement flow diagram from the exten-
sion to trials randomised in clusters [46]. Quantitative
data will be analysed using Stata version 16 or later [47].
Descriptive statistics will summarise outcomes before and
after clusters cross over to the intervention [48]. Normally
distributed variables will be summarised by means and
standard deviations, skewed continuous variables by me-
dians and interquartile ranges, categorical variables by fre-
quencies and percentages. We will estimate the treatment
effect using a cross-classified linear mixed effects model.
A statistical analysis plan will be agreed and signed off
prior to final analysis commencing. Thematic analysis of
qualitative data will be carried out using a constant com-
parison method of analysis, which will gather and generate
ideas and categories through inductive processes. The
computer package NVivo will be used to support the pri-
mary data analysis [49]. Memo writing will be carried out
to describe details of the interview setting and interaction
of respondent and interviewer that may not be captured
in audio transcriptions. This thematic analysis has deduct-
ive and inductive elements, lending itself to multidisciplin-
ary health research [50]. The analysis framework will
incorporate the key theoretical constructs and respond to
the context of policy and practice to include a range of
deductive themes. Further themes will be induced from
the interview data.
An appropriate balance of integration between empi-
rical data and interpretation will be ensured. The investi-
gators will extract the meaning of the empirical data and
interpret them whilst acknowledging the complexity of
the phenomena of CVD risk reduction in the context of
community engagement [51]. This method holds links
to the original data and the output allows comprehen-
sive and transparent data analysis.
Discussion
Given that the rolling out of the NHS Health Checks
programme over and above current care across the UK
has not been implemented as efficiently as it could have
been, especially in some of the most disadvantaged groups
prone to developing CVD, the project aims to scale-up
packages of interventions for cardiovascular prevention
particularly to these vulnerable populations. This interdis-
ciplinary project includes public health, social and behav-
ioural science approaches. The main focus of this project
is the de-institutionalization of health care by operating
outside of formal healthcare settings. The project will
place emphasis on the power of citizens, combining their
efforts to generate cultures of care which complement or
even compensate for the inadequacies of formal systems
and are thus more sustainable. The research project will
ultimately develop a community engagement-based CVD
primary prevention programme to support or enhance the
performance of the NHS health care.
We have considered the potential operational issues in per-
forming the study and have carefully thought out mecha-
nisms to mitigate these. The following potential practical
Fig. 1 Process evaluation model by Moore et al. [45]
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challenges in implementing the project have been identified:
retaining the volunteers, retaining the research participants,
and maintaining the quality of goal setting and motivational
interviewing for an effective behaviour change intervention.
In order to retain the volunteers, we will recruit staff on a
paid basis from each site to work closely with the volunteers.
We will conduct risk assessment audits together with the site
staff so that additional needs of the volunteers, generated by
their participation in the study, can be met. The research
team will liaise with the paid site staff to take steps to ensure
the volunteers are engaged and enthusiastic about their role
and support them when this is not the case. In order to en-
sure retention of the research participants, the researchers
will work very closely with the volunteers. The researcher
will be present in a number of motivational interviewing ses-
sions (with participants’ consent) and become familiar with
the participants’ experiences and circumstances. As the par-
ticipants come from a low socio-economic background it is
likely that they might drop out from the study due to other
pressures in their everyday lives. We will try to identify such
potential threats among the participants and encourage the
volunteers to pre-empt any lack of engagement by discussing
strategies for maintaining motivation with their participants.
The motivational interviews will be quality checked at inter-
vals by researchers and trainers by observing some of these
sessions (with participants’ consent). A regular feedback
mechanism and tailored training plan are in place to improve
the interview quality when any weakness is identified. With
this carefully designed risk mitigation plan we hope to make
sure the project meets its goals.
With our approach of taking cardiovascular disease pre-
vention out of formal healthcare services and bringing it
into the control of people in their own communities we
hope to co-design a sustainable and scalable intervention
which enables members of low SES communities in the
UK to take control of their cardiovascular health, and
improve their quality of life.
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